Certain Common Shares of Tenon Medical, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2023.
September 12, 2023
Share
Certain Common Shares of Tenon Medical, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2023. These Common Shares will be under lockup for 91 days starting from 14-JUN-2023 to 13-SEP-2023.
Details:
Each of its officers and directors has agreed, for a period of ninety (90) days after the closing of this offering, subject to certain exceptions, not to offer, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any shares of its common stock or other securities convertible into or exercisable or exchangeable for shares of common stock without the prior written consent of the placement agent.
Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.